I am a scientist, businessman, author, and philanthropist. For nearly two decades, I was a professor at Harvard Medical School and Harvard School of Public Health where I founded two academic research departments, the Division of Biochemical Pharmacology and the Division of Human
A New Target To Boost Cancer Immunotherapy: LAG-3
Researchers are targeting a novel protein called LAG-3 to improve responses to cancer immunotherapies such as checkpoint inhibitors.
Cancer Therapy and The Intestinal Microbiome
Secrets in the intestinal microbiome may shed light on how to enhance cancer immunotherapies such as checkpoint inhibitors.
How Cancer Immunotherapy Checkpoint Inhibitors Work
Checkpoint inhibitors can treat many different types of cancer. Its key to success lies in blocking one of cancer’s main defenses: checkpoint proteins.
A Breakthrough In Osteoporosis Treatment
Osteoporosis causes up to 37 million fragility fractures in individuals aged over 55, which equates to about 70 fractures per minute globally. The need for effective treatments has never been more urgent.
Telomeres, Or How Your DNA Shrinks Over Time
Telomeres, tiny structures found at the ends of our chromosomes, are crucial to our understanding of aging. Could they be the secret to longer, healthier lives?